The captured endoscopic images were transferred to the DNUC. Superimposed...
The captured endoscopic images were transferred to the DNUC. Superimposed images were created from the original endoscopic image by filling in the tiles with a specific translucent color. The fill color and transmittance were determined corresponding to the result and to the probability of the score. The scientists designed the DNUC to output the following results: (1) endoscopic remission (yes/no), (2) histological remission (yes/no), and (3) the UCEIS score. In the determination of endoscopic remission, the DNUC showed high degrees of diagnostic accuracy (90.1%). Regarding the prediction of histological remission, the DNUC showed high diagnostic accuracy (92.9%).
Source: Tokyo Medical and Dental University

Using AI to assess ulcerative colitis

Researchers develop an AI system that effectively evaluates endoscopic mucosal findings from patients with ulcerative colitis without the need for biopsy collection.

Assessments of patients with ulcerative colitis (UC), which is a type of inflammatory bowel disease, are usually conducted via endoscopy and histology. But now, researchers from Japan have developed a system that may be more accurate than existing methods and may reduce the need for these patients to undergo invasive medical procedures. Researchers from Tokyo Medical and Dental University (TMDU) have revealed a newly developed AI system that can evaluate endoscopic findings of UC with an accuracy equivalent to that of expert endoscopists.

Accurate evaluations are critical in providing optimal care for patients with UC. Previous studies have indicated that both endoscopic remission, evaluated via assessment of endoscopic procedure, and histological remission, as indicated by the degree of microscopic inflammation, can predict patient outcomes, and are thus frequently used as treatment goals. However, intra- and inter-observer variations occur in both endoscopic and histological analyses, and histological analysis frequently requires the collection of tissue via biopsies, which are invasive and costly.

“The interpretation of endoscopic images is subjective and based on the experience of individual endoscopists, thereby making the standardization of evaluation and real-time characterization challenging,” says lead author of the study Kento Takenaka. “To address this, we sought to develop a deep neural network (DNN) system for consistent, objective, and real-time analysis of endoscopic images from patients with UC (DNUC).”

To do this, the researchers developed a system with DNNs to evaluate endoscopic images from patients with UC. DNNs are a type of AI machine-learning method that is based on the construction of artificial neural networks. “We constructed the DNUC algorithm, using 40,758 images of colonoscopies and 6885 biopsy results from 2012 patients with UC,” says senior author Mamoru Watanabe. “This comprised the training set for machine-learning, which enabled the algorithm to learn to accurately evaluate and classify the data”.

The researchers then validated the accuracy of the DNUC algorithm using 4187 endoscopic images and 4104 biopsy specimens from 875 patients with UC. “We found that the DNUC achieved a level of accuracy that was equivalent to that of expert endoscopists,” says Takenaka. “Thus, our system was able to predict histologic remission from UC using endoscopic images only, as opposed to both histological and endoscopic data. This represents an important development given the costs and risks associated with biopsies.”

The DNUC may be able to identify UC patients who are in remission without requiring them to undergo biopsy collection and analysis. This could save time and money for medical institutions, and limit exposure to invasive medical procedures for individuals with UC.

Subscribe to our newsletter

Related articles

AI in healthcare – hype, hope and reality

AI in healthcare – hype, hope and reality

Currently, we are too focused on the topic of AI. In order, however, to leverage AI technology several challenges have to be mastered and a proper framework has to be established.

AI taps human wisdom for better cancer diagnosis

AI taps human wisdom for better cancer diagnosis

A new system combining artificial intelligence with human knowledge promises faster and more accurate cancer diagnosis.

AI analyzes myoclonus severity from video footage

AI analyzes myoclonus severity from video footage

Thanks to a deep convolutional neural network architecture, fast, reliable and automatic assessment of the severity of myoclonic jerks from video footage is now possible.

Using AI to detect and grade prostate cancer

Using AI to detect and grade prostate cancer

Researchers have developed a method based on artificial intelligence for histopathological diagnosis and grading of prostate cancer.

Sensor chip detects cancer biomarker in urine

Sensor chip detects cancer biomarker in urine

Researchers have used a chip-based sensor with an integrated laser to detect very low levels of a cancer protein biomarker in a urine sample.

Using AI to predict risk of thyroid cancer on ultrasound

Using AI to predict risk of thyroid cancer on ultrasound

Researchers from Thomas Jefferson University use machine learning on ultrasound images of thyroid nodules to predict risk of malignancy.

Combination of AI and radiologists accurately identified breast cancer

Combination of AI and radiologists accurately identified breast cancer

An AI tool identified breast cancer with approximately 90 percent accuracy when combined with analysis by radiologists.

Microscopy and VR illuminate new ways to treat disease

Microscopy and VR illuminate new ways to treat disease

Researchers are pairing a nanoscale imaging technique with virtual reality technology to create a method that allows researchers to “step inside” their biological data.

AI used to screen for FASD

AI used to screen for FASD

Scientists have developed a new tool that can screen children for fetal alcohol spectrum disorder (FASD) quickly and affordably.

Popular articles